Pharmacogenetic testing in population of South Ural.
CONCLUSIONS: It was revealed that 75,9% of patients were sensitive to clopidogrel, and for them this drug in its standard dosage will be effective, and 24,1% of patients were not sensitive, therefore, they would require replacement of clopidogrel with another drug.
PMID: 26639695 [PubMed - in process]
Source: International Journal of Risk and Safety in Medicine - Category: Drugs & Pharmacology Tags: Int J Risk Saf Med Source Type: research
More News: Angioplasty | Cardiology | Clopidogrel | Coronary Angioplasty | Drugs & Pharmacology | Genetics | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Statistics | Stroke